Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 620,000 | |||
2 | Avg patent value: 14,340 | |||
3 | Avg patent value: 14,000 | |||
4 | Avg patent value: 3,700 | |||
5 | Avg patent value: 3,600 |
Top 5 Key Players companies in Liquid biopsy
by Highest Patent Value in the South Korea in 2022
The Liquid biopsy top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Liquid biopsy Key Players in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.
Page generation time:
May 12 2025